CD4 and neoplasm: In line with the aforementioned findings, in our lung tumor setting activin-A was elevated in the serum and lungs of tumor-bearing mice, perhaps as part of a defense mechanism, that aims to target CD4+ T cells and endow them with enhanced effector properties.